Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

This is the authors' abstract. We don't add key points for this paper.

The efficacy of allogeneic hematopoietic stem cell transplantation (HSCT) is challenged by acute and chronic graft-versus-host disease and viral infections due to long-lasting immunodeficiency. Interleukin-7 (IL-7) is a cytokine essential for de novo T-cell generation in thymus and peripheral T cell homeostasis. In this study, we investigated the impact of the single nucleotide polymorphism rs6897932 in the IL-7 receptor α-chain (IL-7Rα) which has previously been associated with several autoimmune diseases. We included 460 patients undergoing allogeneic HSCT after a myeloablative conditioning. Patients had a median age of 26.3 years (0.3-67.0 years), and 372 (80.9%) underwent HSCT for malignant diseases. Donors were matched sibling donors (n=147), matched unrelated donors (n=244) or mismatched unrelated donors (n=69), and the stem cell source were either bone marrow (n=329) or peripheral blood (n=131). DNA from donors was genotyped for the IL-7Rα SNP rs6897932 using an allele-specific primer extension assay (CC: n=252, CT: n=178; TT: n=30). The donor T allele was associated with a higher risk of grade III-IV acute GVHD (HR=2.0, 95% CI=1.1-3.8, P=0.034) and with significantly increased risk of extensive chronic GVHD (HR=2.0, 95% CI=1.1-3.6, P=0.025) after adjustment for potential risk factors. In addition, the TT genotype was associated with a higher risk of CMV infection post-transplant (HR=2.4, 95% CI=1.2-4.3, P=0.0068). Numbers of T cells were significantly higher on day +60 in patients receiving a rs6897932 TT graft (CD3+: 109% increase, P=0.0096; CD4+: 64% increase, P=0.038; CD8+: 133% increase, P=0.011). Donor heterozygosity for the T allele was associated with inferior overall survival (HR=1.7, 95% CI=1.2-2.3, P=0.0027) and increased TRM (HR=2.3, 95% CI=1.3-4.0, P=0.0047), but was not associated with the risk of relapse (P=0.35). In conclusion, the IL-7Rα rs6897932 genotype of the donor is predictive of acute and chronic GVHD, CMV infection and mortality following HSCT. These findings indicate that IL-7Rα SNP typing of donors may optimize donor selection and facilitate individualization of treatment in order to limit treatment-related complications.